APA (7th ed.) Citation

Taha, M., Elazab, S. T., Badawy, A. M., Saati, A. A., Qusty, N. F., Al-Kushi, A. G., . . . Farage, A. E. Correction: Taha et al. Activation of SIRT-1 Pathway by Nanoceria Sheds Light on Its Ameliorative Effect on Doxorubicin-Induced Cognitive Impairment (Chemobrain): Restraining Its Neuroinflammation, Synaptic Dysplasticity and Apoptosis. <i>Pharmaceuticals</i> 2022, <i>15</i>, 918. MDPI AG.

Chicago Style (17th ed.) Citation

Taha, Medhat, Sara T. Elazab, Alaa. M. Badawy, Abdullah A. Saati, Naeem F. Qusty, Abdullah G. Al-Kushi, Anas Sarhan, Amira Osman, and Amira E. Farage. Correction: Taha Et Al. Activation of SIRT-1 Pathway by Nanoceria Sheds Light on Its Ameliorative Effect on Doxorubicin-Induced Cognitive Impairment (Chemobrain): Restraining Its Neuroinflammation, Synaptic Dysplasticity and Apoptosis. <i>Pharmaceuticals</i> 2022, <i>15</i>, 918. MDPI AG.

MLA (9th ed.) Citation

Taha, Medhat, et al. Correction: Taha Et Al. Activation of SIRT-1 Pathway by Nanoceria Sheds Light on Its Ameliorative Effect on Doxorubicin-Induced Cognitive Impairment (Chemobrain): Restraining Its Neuroinflammation, Synaptic Dysplasticity and Apoptosis. <i>Pharmaceuticals</i> 2022, <i>15</i>, 918. MDPI AG.